DISCONTINUATION RATES ACROSS THREE PHASE III TRIALS OF THE AMPA RECEPTOR ANTAGONIST PERAMPANEL AS AN ADJUNCTIVE TREATMENT FOR REFRACTORY PARTIAL SEIZURES

被引：0
|
作者：
Yang, H. [1 ]
Squillacote, D. [2 ]
Zhu, J. [1 ]
Laurenza, A. [1 ]
Satlin, A. [1 ]
Kramer, L. D. [1 ]
机构：
[1] Eisai Neurosci Prod Creat Unit, Woodcliff Lake, NJ USA
[2] Eisai Global Med Affairs, Woodcliff Lake, NJ USA
来源：
EPILEPSIA | 2013年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [41] Clinical Factors Associated with a Major Response (≥75% Reduction in Seizure Frequency/28 Days) in Phase III Trials of Adjunctive Perampanel in Patients with Partial Seizures: Post Hoc Multivariate Analysis
    Ben-Menachem, Elinor
    Krauss, Gregory
    Wechsler, Robert T.
    Patten, Anna
    Williams, Betsy
    Laurenza, Antonio
    NEUROLOGY, 2018, 90
  • [42] Clinical Factors Associated with a Major Response (≥75% Reduction in Seizure Frequency/28 Days) in Phase III Trials of Adjunctive Perampanel in Patients with Partial Seizures: Post Hoc Multivariate Analysis
    Ben-Menachem, E.
    Krauss, G. L.
    Wechsler, R. T.
    Patten, A.
    Williams, B.
    Laurenza, A.
    EPILEPSIA, 2018, 59 : S76 - S76
  • [43] Efficacy of Adjunctive Perampanel in Phase III Clinical Trials: Subanalysis of Change in Seizure Frequency and Responder Rates by Concomitant Antiepileptic Drug Use
    French, Jacqueline
    Ben-Menachem, Elinor
    Brodie, Martin
    Squillacote, David
    Yang, Haichen
    Kumar, Dinesh
    Laurenza, Antonio
    NEUROLOGY, 2012, 78
  • [44] LONG-TERM SEIZURE OUTCOMES WITH PERAMPANEL IN REFRACTORY PARTIAL-ONSET SEIZURES AND SECONDARILY GENERALIZED PARTIAL SEIZURES: 10-MONTHS ADDITIONAL DATA FROM EXTENSION STUDY 307 FOLLOWING 3 PHASE III CLINICAL TRIALS
    Ben-Menachem, E.
    Krauss, G. L.
    Bagul, M.
    Zhu, J.
    Gee, M.
    EPILEPSIA, 2013, 54 : 175 - 175
  • [45] IMPACT OF CONCOMITANT SODIUM CHANNEL BLOCKER ANTIEPILEPTIC DRUGS (AEDs) ON THE EFFICACY OF ADJUNCTIVE PERAMPANEL FOR PARTIAL-ONSET SEIZURES: AN ANALYSIS OF POOLED PHASE III DATA
    Kwan, P.
    Brodie, M.
    Squillacote, D.
    Yang, H.
    Zhu, J.
    Laurenza, A.
    EPILEPSIA, 2013, 54 : 167 - 167
  • [46] Time to onset of sustained ≥50% responder status in patients with focal (partial-onset) seizures in three phase III studies of adjunctive brivaracetam treatment
    Klein, Pavel
    Johnson, Martin E.
    Schiemann, Jimmy
    Whitesides, John
    EPILEPSIA, 2017, 58 (02) : E21 - E25
  • [47] Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures
    Abou-Khalil, Bassel
    Klein, Pavel
    Shah, Aashit
    Ryvlin, Philippe
    Specchio, Luigi M.
    Gama, Helena
    Rocha, Francisco
    Blum, David
    Grinnell, Todd
    Cheng, Hailong
    Jung, JungAh
    EPILEPSY RESEARCH, 2018, 147 : 80 - 86
  • [48] Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307
    Krauss, Gregory L.
    Perucca, Emilio
    Ben-Menachem, Elinor
    Kwan, Patrick
    Shih, Jerry J.
    Clement, Jean-Francois
    Wang, Xuefeng
    Bagul, Makarand
    Gee, Michelle
    Zhu, Jin
    Squillacote, David
    EPILEPSIA, 2014, 55 (07) : 1058 - 1068
  • [49] Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studies
    Ko, David
    Yang, Haichen
    Williams, Betsy
    Xing, Dongyuan
    Laurenza, Antonio
    EPILEPSY & BEHAVIOR, 2015, 48 : 45 - 52
  • [50] Determination of the Minimal Clinically Important Difference (MCID) in Seizure Frequency in Three Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL) for Partial-onset (Focal) Seizures (POS)
    Cheng, Hailong
    Tosiello, Robert
    Blum, David
    NEUROLOGY, 2018, 90
12345